Cambrex Corporation Healthcare | Biotechnology | USA Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. The company's products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as other fine chemicals. It serves generic drug companies; and companies that discover and commercialize small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.
This stock recently reported 1Q16, and exceeded expectations. Q1 EPS of $0.50 (+72% Y/Y) beats by $0.16. Revenue of $93.43M (+20.2% Y/Y) beats by $9.82M. Remarkably it's a biotech that sells generic drugs. And is near all time highs, with positive momentum. In 1Q16.
